Astrazeneca Pharma India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2026 inter alia to consider and approve the Un-audited Financial Results of the Company for the quarter and half year ended September 30 2026.We also confirm that the Trading Window remains closed for all Designated Persons from September 16 2026 to November 7 2026 (both days inclusive) in terms of AstraZeneca Pharma India Limited - Code of Conduct for Prevention of Insider Trading framed under Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations 2015.
Ask Value Research 
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
